Literature DB >> 23235540

An improved method of renal tissue engineering, by combining renal dissociation and reaggregation with a low-volume culture technique, results in development of engineered kidneys complete with loops of Henle.

C-Hong Chang1, Jamie A Davies.   

Abstract

BACKGROUND: Tissue engineering of functional kidney tissue is an important goal for clinical restoration of renal function in patients damaged by infectious, toxicological, or genetic disease. One promising approach is the use of the self-organizing abilities of embryonic kidney cells to arrange themselves, from a simply reaggregated cell suspension, into engineered organs similar to fetal kidneys. The previous state-of-the-art method for this results in the formation of a branched collecting duct tree, immature nephrons (S-shaped bodies) beside and connected to it, and supportive stroma. It does not, though, result in the significant formation of morphologically detectable loops of Henle - anatomical features of the nephron that are critical to physiological function.
METHODS: We have combined the best existing technique for renal tissue engineering from cell suspensions with a low-volume culture technique that allows intact kidney rudiments to make loops of Henle to test whether engineered kidneys can produce these loops.
RESULTS: The result is the formation of loops of Henle in engineered cultured 'fetal kidneys', very similar in both morphology and in number to those formed by intact organ rudiments.
CONCLUSION: This brings the engineering technique one important step closer to production of a fully realistic organ.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 23235540     DOI: 10.1159/000345514

Source DB:  PubMed          Journal:  Nephron Exp Nephrol        ISSN: 1660-2129


  24 in total

Review 1.  Experimental renal progenitor cells: repairing and recreating kidneys?

Authors:  Paul J D Winyard; Karen L Price
Journal:  Pediatr Nephrol       Date:  2013-11-13       Impact factor: 3.714

2.  The generation of kidney organoids by differentiation of human pluripotent cells to ureteric bud progenitor-like cells.

Authors:  Yun Xia; Ignacio Sancho-Martinez; Emmanuel Nivet; Concepcion Rodriguez Esteban; Josep Maria Campistol; Juan Carlos Izpisua Belmonte
Journal:  Nat Protoc       Date:  2014-10-23       Impact factor: 13.491

3.  From human pluripotent stem cells to functional kidney organoids and models of renal disease.

Authors:  Susan J Kimber; Adrian S Woolf
Journal:  Stem Cell Investig       Date:  2018-07-21

Review 4.  Renal stem cell reprogramming: Prospects in regenerative medicine.

Authors:  Elvin E Morales; Rebecca A Wingert
Journal:  World J Stem Cells       Date:  2014-09-26       Impact factor: 5.326

Review 5.  The inter-dependence of basic and applied biomedical sciences: Lessons from kidney development and tissue-engineering.

Authors:  Jamie A Davies
Journal:  Porto Biomed J       Date:  2017-09-01

Review 6.  Modeling renal progenitors - defining the niche.

Authors:  Shunsuke Tanigawa; Alan O Perantoni
Journal:  Differentiation       Date:  2016-02-05       Impact factor: 3.880

Review 7.  Concise Review: Understanding the Renal Progenitor Cell Niche In Vivo to Recapitulate Nephrogenesis In Vitro.

Authors:  Chiara Mari; Paul Winyard
Journal:  Stem Cells Transl Med       Date:  2015-10-22       Impact factor: 6.940

8.  Maintenance of Mouse Nephron Progenitor Cells in Aggregates with Gamma-Secretase Inhibitor.

Authors:  Shunsuke Yuri; Masaki Nishikawa; Naomi Yanagawa; Oak D Jo; Norimoto Yanagawa
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

9.  Sebinger Culture: A System Optimized for Morphological Maturation and Imaging of Cultured Mouse Metanephric Primordia.

Authors:  Mona Elhendawi; Jamie A Davies
Journal:  Bio Protoc       Date:  2018-02-20

10.  Transport of organic anions and cations in murine embryonic kidney development and in serially-reaggregated engineered kidneys.

Authors:  Melanie L Lawrence; C-Hong Chang; Jamie A Davies
Journal:  Sci Rep       Date:  2015-03-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.